Adriana Peleteiro-Soto

Barakaldo, PV, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Recurrent fever and association with severe organ involvement, mortality and treatment outcomes in VEXAS syndrome: data from the AIDA Network.

Journal: Frontiers in immunology

Published: November 24, 2025

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

VEXAS syndrome and cancer: Insights about a possible "Tip of the Iceberg". Ambidirectional data from the international AIDA network registries.

Journal: Seminars in arthritis and rheumatism

Published: November 14, 2025

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Journal: Frontiers in immunology

Published: September 19, 2025

Methylprednisolone plus MTX-based regime vs prednisone-based standard of care for GCA: a propensity score study.

Methylprednisolone plus MTX-based regime vs prednisone-based standard of care for GCA: a propensity score study.

Journal: Rheumatology (Oxford, England)

Published: July 01, 2025

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.

Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network.

Journal: Frontiers in pharmacology

Published: December 04, 2024

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Efficacy and safety profile of biotechnological agents and Janus kinase inhibitors in VEXAS syndrome: data from the international AIDA Network VEXAS registry.

Journal: Frontiers in pharmacology

Published: July 09, 2024

Catastrophic antiphospholipid syndrome with massive cerebral venous sinus thrombosis.

Catastrophic antiphospholipid syndrome with massive cerebral venous sinus thrombosis.

Journal: Clinical and experimental rheumatology

Published: May 14, 2024

Obstetric antiphospholipid syndrome.

Obstetric antiphospholipid syndrome.

Journal: Medicina clinica

Published: January 24, 2024

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.

Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry.

Journal: Seminars in arthritis and rheumatism

Published: November 28, 2023

Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.

Ocular involvement in adult and paediatric patients with monogenic autoinflammatory diseases: a Spanish multicentre retrospective study.

Journal: Clinical and experimental rheumatology

Published: May 07, 2023

ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study.

ANCA-associated pulmonary-renal syndrome treated with cyclophosphamide, rituximab, repeated methyl-prednisolone pulses and a reduced oral glucocorticoid regime: an observational study.

Journal: Clinical and experimental rheumatology

Published: December 26, 2022

IgG4 related disease as a mimicker of metastatic pancreatic cancer.

IgG4 related disease as a mimicker of metastatic pancreatic cancer.

Journal: Revista espanola de enfermedades digestivas

Published: March 17, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026